Definer Pharmaceuticals Private Limited
About Definer Pharmaceuticals Private Limited
Data last updated:
Definer Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 11 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U93090UP2014PTC063284. Its GSTIN is 09AAFCD7017G1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Sharma and Sushma Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 554/172/7 Chhota Baraha, Lucknow, Uttar Pradesh, India – 226005.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.42 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹10.24 Lakh (net margin 3%) and EBITDA of ₹18.22 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Definer Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address554/172/7 Chhota Baraha, Lucknow, Uttar Pradesh, India – 226005
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Definer Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Definer Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Definer Pharmaceuticals Private Limited, buy the company report.
Financials of Definer Pharmaceuticals Private Limited
FY 2025 filings availableDefiner Pharmaceuticals Private Limited reported revenue of ₹3.42 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Definer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Definer Pharmaceuticals Private Limited
Definer Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Sharma | Director | 11 Mar 2014 | 12 Years 7 Months | Current |
| Sushma Sharma | Director | 11 Mar 2014 | 12 Years 7 Months | Current |
Peer comparison
Definer Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axter Pharmaceuticals Private Limited | ₹3.43 Cr (FY 2025) | 27.0% | Ahmedabad, Gujarat, India | |||
| Definer Pharmaceuticals Private Limitedthis company | ₹3.42 Cr (FY 2025) | ₹10.24 Lakh | 3% | 9.0% | Lucknow, Uttar Pradesh, India | |
| Maxzimaa Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Centenary Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | 49.0% | Pune, Maharashtra, India |
To see the full peer comparison of Definer Pharmaceuticals Private Limited, buy the company report.
Auditor
Definer Pharmaceuticals Private Limited is audited by SINGHANIA ATUL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGHANIA ATUL & ASSOCIATES | FY 2017 | 079155 |
Shareholding
The shareholding of Definer Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Definer Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Definer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Definer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Definer Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCD7017G1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Definer Pharmaceuticals Private Limited, buy the company report.
Recent activity
Definer Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Amit Sharma was appointed as Director on 11 Mar 2014.
Frequently asked questions
Definer Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 11 March 2014 (12+ years old) and is registered under CIN U93090UP2014PTC063284.
Definer Pharmaceuticals has 2 current directors:
- Amit Sharma - Director
- Sushma Sharma - Director
The latest financial statements of Definer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Definer Pharmaceuticals is 09AAFCD7017G1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Definer Pharmaceuticals is U93090UP2014PTC063284. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Definer Pharmaceuticals was incorporated on 11 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Definer Pharmaceuticals by revenue are Axter Pharmaceuticals Private Limited, Maxzimaa Pharmaceuticals Private Limited, Centenary Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Sharma was appointed as Director on 11 Mar 2014. Sushma Sharma was appointed as Director on 11 Mar 2014.
The registered office of Definer Pharmaceuticals is at 5541727 Chhota Baraha, Lucknow, Uttar Pradesh, India – 226005.
Definer Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Definer Pharmaceuticals is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.